Back to Journals » Journal of Pain Research » Volume 4

Tapentadol extended-release for treatment of chronic pain: a review

Authors Vadivelu N, Timchenko, Huang, Sinatra R

Published 1 August 2011 Volume 2011:4 Pages 211—218

DOI https://doi.org/10.2147/JPR.S14842

Review by Single-blind

Peer reviewer comments 2

Nalini Vadivelu1, Alexander Timchenko1, Yili Huang2, Raymond Sinatra1
1Department of Anesthesiology, Yale University School of Medicine, New Haven, CT; 2Internal Medicine, North Shore-LIJ Plainview Hospital, Plainview, NY, USA

Abstract: Tapentadol is a centrally acting analgesic with a dual mechanism of action of mu receptor agonism and norepinephrine reuptake inhibition. Tapentadol immediate-release is approved by the US Food and Drug Administration for the management of moderate-to-severe acute pain. It was developed to decrease the intolerability issue associated with opioids. Tapentadol extended-release has a 12-hour duration of effect, and has recently been evaluated for pain in patients with chronic osteoarthritis, low back pain, and pain associated with diabetic peripheral neuropathy. Tapentadol extended-release was found to provide safe and highly effective analgesia for the treatment of chronic pain conditions, including moderate-to-severe chronic osteoarthritis pain and low back pain. Initial trials demonstrating efficacy in neuropathic pain suggest that tapentadol has comparable analgesic effectiveness and better gastrointestinal tolerability than opioid comparators, and demonstrates effectiveness in settings of inflammatory, somatic, and neuropathic pain. Gastrointestinal intolerance and central nervous system effects were the major adverse events noted. Tapentadol will need to be rigorously tested in chronic neuropathic pain, cancer-related pain, and cancer-related neuropathic pain.

Keywords: osteoarthritis, neuropathic pain, analgesic, opioids, norepinephrine

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Challenges of pain control and the role of the ambulatory pain specialist in the outpatient surgery setting

Vadivelu N, Kai AM, Kodumudi V, Berger JM

Journal of Pain Research 2016, 9:425-435

Published Date: 17 June 2016

Options for perioperative pain management in neurosurgery

Vadivelu N, Kai AM, Tran D, Kodumudi G, Legler A, Ayrian E

Journal of Pain Research 2016, 9:37-47

Published Date: 10 February 2016

Tapentadol extended release in the management of peripheral diabetic neuropathic pain

Vadivelu N, Kai A, Maslin B, Kodumudi G, Legler A, Berger JM

Therapeutics and Clinical Risk Management 2015, 11:95-105

Published Date: 14 January 2015

Patient considerations in the use of tapentadol for moderate to severe pain

Vadivelu N, Huang Y, Mirante B, Jacoby M, Braveman FR, Hines RL, Sinatra R

Drug, Healthcare and Patient Safety 2013, 5:151-159

Published Date: 3 July 2013

Readers of this article also read:

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Evaluation of in vitro glistening formation in hydrophobic acrylic intraocular lenses

Thomes BE, Callaghan TA

Clinical Ophthalmology 2013, 7:1529-1534

Published Date: 25 July 2013

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Corrigendum: Softec HD hydrophilic acrylic intraocular lens: biocompatibility and precision

Espandar L, Sikder S, Moshirfar M

Clinical Ophthalmology 2011, 5:159-160

Published Date: 6 February 2011

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010

Wound care in the geriatric client

Steve Gist, Iris Tio-Matos, Sharon Falzgraf, Shirley Cameron, Michael Beebe

Clinical Interventions in Aging 2009, 4:269-287

Published Date: 8 June 2009